Gilead Sciences, Inc. (GILD) Stock Price Today
Barclays keeps 'Underweight' on Target despite raising price target to $140 amid strong Q2 results.
Barclays maintained an "Underweight" rating on Target's stock but raised its price target from $115 to $140, even though Target's shares trade above $161. This cautious stance reflects concerns that Target may underperform its peers despite a strong ...
Sea Limited director sells 20,000 shares worth $2.4 million
Heng Chen Seng, a director at Sea Limited, sold 20,000 shares valued at $2.4 million. This insider sale may indicate personal portfolio adjustments but does not necessarily reflect company performance. Investors should monitor further insider activit...
Moderna shares soar over 160% after positive Phase 3 melanoma vaccine trial results
Moderna and Merck announced successful Phase 3 trial results for their personalized mRNA melanoma vaccine combined with Keytruda, showing significant improvement in recurrence-free and distant metastasis-free survival. This marks the first positive l...
Ark Invest buys $27M Nvidia and $16M Broadcom amid market sell-off, signaling potential buying opportunity.
During the recent market sell-off, Cathie Wood's Ark Invest purchased $27 million worth of Nvidia shares and $16 million of Broadcom shares. These significant buys by a well-known investor suggest confidence in these tech stocks despite broader marke...
Walmart downgraded amid e-commerce challenges ahead of Q2 earnings report
Walmart faces increased competition from Amazon in higher-margin retail categories despite leading U.S. grocery spending. Oppenheimer downgraded Walmart from "Outperform" to "Perform" and removed its $140 price target, citing risks including pharmacy...
Director Carande buys 2,101 shares of United Community Banks, signaling confidence.
Director Carande has purchased 2,101 shares of United Community Banks. This insider buying may indicate confidence in the company's future prospects. Investors often view such transactions as a positive signal, potentially influencing market sentimen...
Bio-Techne Q4 revenue beats estimates; Merck KGaA acquisition keeps stock near $73 offer price.
Bio-Techne reported Q4 revenues of $321.2 million, slightly surpassing estimates, but its adjusted EPS fell 1.9% year-over-year to $0.52, showing mixed financial results. The company's stock remains close to Merck KGaA's $73 per share acquisition off...
Estée Lauder beats earnings estimates with strong sales growth and optimistic outlook
Estée Lauder reported quarterly earnings per share of $0.39, surpassing analyst estimates of $0.32, and revenue of $3.62 billion, exceeding expectations. The company showed 5% organic sales growth for the fourth consecutive quarter and raised its ful...
HP expects stable full-year guidance despite margin pressure from rising memory chip costs
HP Inc is set to maintain its full-year guidance in its upcoming fiscal Q3 report, despite rising memory chip costs squeezing margins in its Personal Systems segment. Bank of America expects slightly better-than-guided revenue in Personal Systems due...
Wendy's shares jump 5% on reports of a potential buyout consortium led by Nelson Peltz's Trian Fund.
Wendy's stock rose 5% after reports that Nelson Peltz's Trian Fund Management is forming a consortium, including BlueFive Capital and Flynn Group, to take the company private. Wendy's also announced it will bring back the chief operating officer role...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.